Cagrilintide 5 mg
A modified amylin analogue investigated in receptor pharmacology and clinical metabolic research.
CAD $100.00 / vial
Vial amount
The specifics, clearly listed.
Product details
Product reference: MRD-0031 Listed amount per vial: 5 mg Sales unit: 1 vial
Read the research in context.
A modified amylin analogue investigated in receptor pharmacology and clinical metabolic research.
- Development of Cagrilintide, a Long-Acting Amylin Analogue — source
- AM833 Is a Novel Agonist of Calcitonin Family G Protein-Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists — source
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial — source
Candidate-molecule or reference-product background; not verification of this supplied product.
What this doesn’t establish: Supplier acylation/linker, sequence/disulfide pattern, terminal state and salt are unverified; do not equate it with cagrilintide–semaglutide coformulations. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.
Product documents
No verified report is available here for this item. Ask about documentation for Cagrilintide, product reference MRD-0031.
Before you decide.
Separate research about the compound from evidence about the supplied product.
Which vial amount is shown?
This listing shows 5 mg per vial.
Does the study verify this vial?
No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.
What should I check in a report?
Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.
What information should I request?
Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.